Etiroxate
Etiroxate (CG-635) is a lipid lowing compound which can be used for hyperlipoproteinemia research[1].
Product Specifications
CAS Number
17365-01-4
Product Name Alternative
CG-635
UNSPSC
12352005
Target
Drug Derivative; Thyroid Hormone Receptor
Type
Reference compound
Related Pathways
Others; Vitamin D Related/Nuclear Receptor
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/etiroxate.html
Solubility
10 mM in DMSO
Smiles
NC(CC1=CC(I)=C(C(I)=C1)OC2=CC(I)=C(O)C(I)=C2)(C)C(OCC)=O
Molecular Formula
C18H17I4NO4
Molecular Weight
818.95
References & Citations
[1]Beckmann R. et al. [Expeimental studies in animals on a new lipid lowering compound: etiroxate hydrochloride (author's transl) ]. Arzneimittelforschung. 1979;29 (3) :499-508.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1497580-01 0.05 mg
Rabbit anti-human Zinc finger and SCAN domain-containing protein 20 polyclonal Antibody, FITC
Sign In for Pricing
View Details MBS1497580-02 0.1 mg
Rabbit anti-human Zinc finger and SCAN domain-containing protein 20 polyclonal Antibody, FITC
Sign In for Pricing
View Details